title: [A new principle for the design of immunotherapeutic compounds of directed action. Physiologically active substances reversibly screened with target-recognizing macromolecules].
authors.forename: V Iu
authors.initials: VIu
authors.lastname: Alakhov
authors.forename: S A
authors.initials: SA
authors.lastname: Arzhakov
authors.forename: O V
authors.initials: OV
authors.lastname: Vasilenko
authors.forename: S G
authors.initials: SG
authors.lastname: Voloshchuk
authors.forename: I S
authors.initials: IS
authors.lastname: Glazkova-Stepanenko
mesh_terms: D001402:B-Lymphocytes / Q000187:drug effects; D015195:Drug Design; D004768:Enterotoxins / Q000494:pharmacology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D000922:Immunotoxins / Q000494:pharmacology*; D008223:Lymphoma / Q000188:drug therapy; D013601:T-Lymphocytes / Q000187:drug effects
chemical_list: D004768:Enterotoxins; D007074:Immunoglobulin G; D000922:Immunotoxins; C026066:enterotoxin A, Staphylococcal
vernacular_title: Novyĭ printsip sozdaniia immunoterapevticheskikh soedineniĭ napravlennogo deĭstviia. Fiziologicheski aktivnye veshchestva, obratimo ékranirovannye mishen'- uznaiushchimi makromolekulami.